HarvestPlus   Report issue

Foundation Phase 2 Phase 3
Founded: Washington D.C. United States (2003)

Organization Overview

First Clinical Trial
2009
NCT01346722
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

HarvestPlus

Active Ingredients

Drugs in Phase 3 Trials (2)

beta carotene (solatene) (2 trials)

corn (2 trials)

Drugs in Phase 2 Trials (1)

zinc (2 trials)

Drugs in Other Trials (1)

millet (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Night Blindness (Phase 3)

Vitamin A Deficiency (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 4